Safety and Efficacy of A-007 Topical Gel in the Treatment of High-Grade Squamous Intraepithelial Lesions (HSIL) of the Cervix

Clinical trial NCT00285207 · COMPLETED

Trial details

NCT number: NCT00285207
Sponsor: Tigris Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cervical Intraepithelial Neoplasia Uterine Cervical Dysplasia

Start date: 2006-01-01
Primary completion: 2008-04-01
Enrollment: 147

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.